Source Credit Virta Health

资料来源：Virta Health

What You Should Know:

你应该知道的：

–

–

Virta Health

维尔塔健康

, a provider of sustainable weight loss and diabetes reversal through a nutrition-first approach, today announced industry-first cost guarantees for its weight loss program.

通过优先营养的方法提供可持续减肥和糖尿病逆转的公司，今天宣布了其减肥计划的行业首个成本保证。

– These guarantees aim to eliminate financial risk for employers and health plans by ensuring Virta’s program pays for itself while also reining in the escalating costs associated with GLP-1 medications, which are reportedly rising 70–200% annually across the industry. Virta now commits to stopping these increases completely, guaranteeing 0% utilization growth for employers offering this drug class for obesity..

这些保障措施旨在通过确保 Virta 项目的自给自足来消除雇主和健康计划的财务风险，同时抑制与 GLP-1 药物相关的成本上涨，据报道该类药物在全行业每年上涨 70%-200%。Virta 现在承诺完全阻止这些增长，保证为肥胖症提供这类药物的雇主实现 0% 的使用率增长。

Tackling Soaring GLP-1 Costs and Ensuring Value for Payers

应对GLP-1成本飙升，确保支付方的价值

The rapidly increasing costs of GLP-1 medications for weight loss, projected to surpass $100 billion annually, are placing enormous financial pressure on employers and health plans. In response, many organizations have opted not to cover these medications for weight loss, or have discontinued coverage after experiencing spiraling costs, often leaving members dissatisfied and without access to treatment..

快速上涨的GLP-1类减肥药物费用，预计每年将超过1000亿美元，给雇主和健康计划带来了巨大的财务压力。对此，许多机构选择不覆盖这些减肥药物的费用，或在经历成本飙升后停止覆盖，这常常导致会员不满且无法获得治疗。

Virta aims to set a new standard by combining outcomes-driven care with cost-conscious, responsible GLP-1 use. The company prioritizes nutrition and utilizes high-quality, name-brand GLP-1 medications only when clinically necessary.

Virta旨在通过将结果导向的护理与具有成本意识、负责任的GLP-1使用相结合来树立新标准。该公司优先考虑营养，并仅在临床必要时使用高质量的品牌GLP-1药物。

Virta’s Dual Cost Guarantees: A New Standard for Weight Loss Programs

Virta的双重成本保证：减肥计划的新标准

Virta’s new, industry-first cost guarantees include:

Virta 的全新、行业首创的成本保证包括：

0% Year-over-Year Growth in GLP-1 Utilization:

GLP-1使用量同比增长0%：

For organizations that offer GLP-1 coverage for obesity, Virta guarantees a 0% year-over-year cost increase related to these medications, as measured by prescription volume.

对于那些提供GLP-1肥胖症覆盖的组织，Virta保证与这些药物相关的成本不会逐年增加，这一保证是通过处方量来衡量的。

1:1 Claims Based ROI:

基于索赔的ROI：

Employers and health plans are assured at least a dollar-for-dollar return in total cost of care savings, based on a rigorous analysis of medical and pharmacy claims—considered the gold standard for assessing economic impact in healthcare.

基于对医疗和药房索赔的严格分析（被认为是评估医疗保健经济影响的黄金标准），雇主和健康计划至少能够确保在总护理成本节省上获得一比一的回报。

These financial assurances are complemented by Virta’s existing industry-leading clinical guarantees, which include a promise to deliver even greater weight loss across entire enrolled populations—whether or not members are using GLP-1 medications—through its Sustainable Weight Loss program with Responsible Prescribing..

这些财务保证是对Virta现有行业领先的临床保障的补充，其中包括通过其“可持续减重与负责任处方”计划，承诺在全体注册人群中实现更大的减重效果——无论成员是否使用GLP-1类药物。

A Nutrition-First Approach with Responsible GLP-1 Management

以营养为先的方法，负责任地管理GLP-1

Virta emphasizes its unique position as the only solution on the market that it claims can match the weight loss results of GLP-1 medications without relying on drugs, while also guaranteeing even greater bodyweight reduction for its members. This enables members to achieve lasting results with or without GLP-1s.

Virta 强调其作为市场上唯一一种无需依赖药物即可匹敌 GLP-1 药物减重效果的解决方案的独特地位，同时保证其会员能够实现更大的体重减轻。这使得会员无论是否使用 GLP-1 药物，都能获得持久的减重效果。

When medications are appropriate, Virta offers flexible solutions to help organizations secure best-in-market pricing on GLP-1s, leveraging unique partnerships with Pharmacy Benefit Managers (PBMs) and direct access to pharmaceutical manufacturers’ consumer pricing..

当药物适用时，Virta 提供灵活的解决方案，帮助组织通过与药品福利管理公司（PBM）的独特合作以及直接获取制药制造商的消费者定价，确保在市场上获得最优的 GLP-1 药品价格。

“These guarantees are a natural extension of our founding mission—to reverse chronic diseases like diabetes and obesity while reducing costs,” said Virta co-founder and CEO Sami Inkinen. “We’ve proven that it’s possible to achieve meaningful, sustainable weight loss with or without lifelong medication use.

“这些保障是我们创始使命的自然延伸——逆转糖尿病和肥胖等慢性疾病，同时降低成本，”Virta联合创始人兼首席执行官Sami Inkinen表示。“我们已经证明，无论是否终身用药，都有可能实现有意义且可持续的减重。”

Now we’re taking the next step: fully aligning our incentives with our customers to help them control costs and deliver better outcomes at the same time”..

现在，我们将采取下一步行动：将我们的激励措施与客户完全对齐，帮助他们控制成本，同时取得更好的成果。